Carlyle Group Inc. — 13F Holdings & Portfolio
CIK 1527166 · latest 13F-HR filed 2026-08-07
Carlyle Group Inc. manages $10.00B in 13F-reported U.S. long-equity assets across 19 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are MDLN (73.78%), SARO (25.30%), PHAT (0.38%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 3 new positions, exited 4, added to 7, and trimmed 7.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$10.00B
Long-equity book
19
Distinct positions
2026-06-30
Filed 2026-08-07
+3 / −4 / ↑7 / ↓7
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
| Name | Title / Status | Ownership | Type |
|---|
Quarter-over-quarter changes
Share-count changes vs the prior 13F.
Top Adds (vs prior quarter)
- Standardaero Inc$345.1M +15.8%
- Invitation Homes Inc$3.5M +21.3%
- SunPower Inc$1.1M +192.8%
- Getty Images Holdings Inc$415.2K +8.4%
- Adicet Bio Inc$337.3K +26.9%
Top Trims
- Medline Inc-$946.6M -11.4%
- Q32 Bio Inc-$6.3M -89.1%
- Pony Ai Inc-$5.9M -26.4%
- Jasper Therapeutics Inc-$485.3K -52.0%
- Spruce Biosciences Inc-$438.3K -17.4%
New Positions
- Riley Exploration Permian In$530.4K
- Nebius Group N.V.$509.8K
- Ramaco Res Inc$287.7K
Exited Positions
- CubeSmart$8.1M
- Heartflow Inc$497.3K
- Spyre Therapeutics Inc$485.2K
- Exicure Inc$239.6K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | Medline Inc | MDLN | 58507V107 | $7.38B | 73.78% | 187,083,713 | SH |
| 2 | Standardaero Inc | SARO | 85423L103 | $2.53B | 25.30% | 84,587,035 | SH |
| 3 | Phathom Pharmaceuticals Inc | PHAT | 71722W107 | $37.9M | 0.38% | 3,496,808 | SH |
| 4 | Invitation Homes Inc | INVH | 46187W107 | $20.0M | 0.20% | 662,900 | SH |
| 5 | Pony Ai Inc | PONY | 732908108 | $16.4M | 0.16% | 2,362,447 | SH |
| 6 | Getty Images Holdings Inc | GETY | 374275105 | $5.4M | 0.05% | 6,234,252 | SH |
| 7 | Spruce Biosciences Inc | SPRB | 85209E208 | $2.1M | 0.02% | 38,620 | SH |
| 8 | SunPower Inc | SPWR | 20460L104 | $1.6M | 0.02% | 2,343,750 | SH |
| 9 | Adicet Bio Inc | ACET | 007002207 | $1.6M | 0.02% | 184,295 | SH |
| 10 | Forward Air Corp | FWRD | 34986A104 | $1.4M | 0.01% | 107,214 | SH |
| 11 | Onkure Therapeutics Inc | OKUR | 68277Q105 | $1.2M | 0.01% | 269,895 | SH |
| 12 | Krispy Kreme Inc | DNUT | 50101L106 | $1.2M | 0.01% | 340,748 | SH |
| 13 | Q32 Bio Inc | QTTB | 746964105 | $769.0K | 0.01% | 60,363 | SH |
| 14 | Riley Exploration Permian In | REPX | 76665T102 | $530.4K | 0.01% | 16,092 | SH |
| 15 | Nebius Group N.V. | NBIS | N97284108 | $509.8K | 0.01% | 1,846 | SH |
| 16 | Robinhood Mkts Inc | HOOD | 770700102 | $474.6K | 0.00% | 4,733 | SH |
| 17 | Jasper Therapeutics Inc | JSPR | 471871202 | $448.9K | 0.00% | 1,066,189 | SH |
| 18 | N-able Inc | NABL | 62878D100 | $344.0K | 0.00% | 93,732 | SH |
| 19 | Ramaco Res Inc | METC | 75134P600 | $287.7K | 0.00% | 21,743 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-07 | $10.00B | 19 | 0000898432-26-000602 |
| 2026-03-31 | 2026-05-08 | $10.62B | 20 | 0000898432-26-000339 |
| 2025-12-31 | 2026-02-13 | $13.57B | 20 | 0000898432-26-000105 |
WASHINGTON, DC 20004